184 related articles for article (PubMed ID: 9870735)
1. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases.
El Rassi Z; Partensky C; Valette PJ; Berger F; Chayvialle JA
Eur J Surg Oncol; 1998 Dec; 24(6):562-7. PubMed ID: 9870735
[TBL] [Abstract][Full Text] [Related]
2. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
Siegel R; Linse R; Rau B
Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
[TBL] [Abstract][Full Text] [Related]
3. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration.
Santangelo WC; Unger RH; Orci L; Dueno MI; Popma JJ; Krejs GJ
Pancreas; 1986; 1(5):464-9. PubMed ID: 2882503
[TBL] [Abstract][Full Text] [Related]
5. Glucagonoma and necrolytic migratory erythema.
Echenique-Elizondo M; Martínez de Lizarduy I
Rev Esp Enferm Dig; 2005 Jun; 97(6):455-7. PubMed ID: 16011420
[No Abstract] [Full Text] [Related]
6. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
Saavedra C; Lamarca A; Hubner RA
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
[TBL] [Abstract][Full Text] [Related]
7. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
8. Glucagonoma syndrome: diagnosis and treatment.
Zeng J; Wang B; Ma D; Li F
J Am Acad Dermatol; 2003 Feb; 48(2):297-8. PubMed ID: 12582409
[No Abstract] [Full Text] [Related]
9. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
10. [Necrolytic migratory erythema].
Dandrifosse JF; Dandrifosse AC; Piérard G; Scheen AJ; Dandrifosse G
Rev Med Liege; 1998 Dec; 53(12):778-83. PubMed ID: 9927878
[TBL] [Abstract][Full Text] [Related]
11. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
Mullans EA; Cohen PR
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):866-73. PubMed ID: 9591806
[TBL] [Abstract][Full Text] [Related]
12. A patient with long-standing skin lesions. Necrolytic migratory erythema.
Netea RT; Erceg A; Pieters G; Hermus AR
Neth J Med; 2004 Dec; 62(11):453, 462. PubMed ID: 15685896
[No Abstract] [Full Text] [Related]
13. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
14. Differentiating non-paraneoplastic from glucagonoma associated necrolytic migratory erythema.
Rohna R; Suraiya HH
Singapore Med J; 1998 Aug; 39(8):385. PubMed ID: 9844504
[No Abstract] [Full Text] [Related]
15. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
16. [Glucagonoma: a recent series of 7 cases].
Vauleon E; Egreteau J; Boucher E; Desfourneaux V; Bretagne JF; Raoul JL
Bull Cancer; 2004; 91(7-8):637-40. PubMed ID: 15381454
[TBL] [Abstract][Full Text] [Related]
17. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
Tolliver S; Graham J; Kaffenberger BH
Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
[TBL] [Abstract][Full Text] [Related]
18. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
Gantcheva ML; Broshtilova VK; Lalova AI
Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
[No Abstract] [Full Text] [Related]
19. Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
Eldor R; Glaser B; Fraenkel M; Doviner V; Salmon A; Gross DJ
Clin Endocrinol (Oxf); 2011 May; 74(5):593-8. PubMed ID: 21470282
[TBL] [Abstract][Full Text] [Related]
20. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.
Kindmark H; Sundin A; Granberg D; Dunder K; Skogseid B; Janson ET; Welin S; Oberg K; Eriksson B
Med Oncol; 2007; 24(3):330-7. PubMed ID: 17873310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
